Suchergebnisse - (Person:"Gökmen-Polar, Yesim")

PubPharm (8)

1

Multi-protein spatial signatures in ductal carcinoma in situ (DCIS) of breast

enthalten in: British journal of cancer | 2021

von Badve, S. | Cho, S. | Gökmen-Polar, Y. | +10

2

CIBERSORT analysis of TCGA and METABRIC identifies subgroups with better outcomes in triple negative breast cancer

enthalten in: Scientific reports | 2021

von Craven, K. | Gökmen-Polar, Y. | Badve, S.

3

Validation of the DNA Damage Immune Response Signature in Patients With Triple-Negative Breast Cancer From the SWOG 9313c Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2019

von Sharma, P. | Barlow, W. | Godwin, A. | +19

4

HSF1 as a Cancer Biomarker and Therapeutic Target

enthalten in: Current cancer drug targets | 2019

von Carpenter, R. | Gökmen-Polar, Y.

5

Single-cell heterogeneity in ductal carcinoma in situ of breast

enthalten in: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc | 2018

von Gerdes, M. | Gökmen-Polar, Y. | Sui, Y. | +6

6

The Integrated Genomic Landscape of Thymic Epithelial Tumors

enthalten in: Cancer cell | 2018

von Radovich, M. | Pickering, C. | Felau, I. | +145

7

2-methoxyestradiol inhibits the anaphase-promoting complex and protein translation in human breast cancer cells

enthalten in: Cancer research | 2007

von Bhati, R. | Gökmen-Polar, Y. | Sledge, G. | +7

8

Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer model

enthalten in: The Prostate | 2006

von Shanmugam, R. | Jayaprakasan, V. | Gokmen-Polar, Y. | +12

1
[1]